PITHD1 (PITH domain containing 1) is a nuclear and cytoplasmic protein with established roles in megakaryocyte differentiation and emerging functions in disease pathology. Primary function: PITHD1 promotes megakaryocyte differentiation by upregulating RUNX1 expression through dual mechanisms—activating the proximal promoter and enhancing translation via an internal ribosome entry site (IRES) element 1. Mechanism: PITHD1 acts as an IRES activator that regulates RUNX1 at both transcriptional and translational levels, with PITHD1 downregulation suppressing differentiation while ectopic expression restores megakaryopoiesis in fetal liver cells 1. Disease relevance: PITHD1 expression is dysregulated across multiple pathological conditions. It is significantly downregulated in chr1 obstructive pulmonary disease (COPD), identified as a miR-125a-5p-related biomarker 2, and shows increased expression in the olfactory system of Alzheimer's disease patients at late stages 3. In clear-cell ovarian carcinoma, lower PITHD1 expression correlates with unfavorable survival 4. Clinical significance: PITHD1 emerges as a potential prognostic biomarker across multiple malignancies and neurodegenerative conditions, with vitreous PITHD1 concentrations correlating with inflammatory markers in vitreoretinal lymphoma 5, suggesting utility in disease stratification and therapeutic development.